Sickle Cell Anemia/Hemophilia Flashcards

1
Q

What are sickle cell syndromes caused by?

A

Inherited disorder of of the B-globin gene
(HbA is normal)
-the alpha chains are normal but there is a substitution of valine for glutamic acid on the beta chains.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is HbF?

A

Fetal hemoglobin

  • 2 alpha chain and 2 gamma chains
  • it is less likely to sickle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is sickle cell trait?

A

Heterozygous =HbAS

  • usually asymptomatic (sometimes can see symptoms at times of high stress or at high altitudes)
  • carriers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

If both mother and father have SCT, what are the changes their child will have SCD, SCT, or normal

A

25% SCD
50% SCT
25% normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is SCD distributed racially and geographically?

A
  • more common in blacks and hispanics

- common worldwide but especially in Africa, India, Saudi Arabia and Mediterranean countries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the genotype of sickle cell disease (SCD)?

A

Homozygous HbSS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are genral long term complications of SCD?

A
  • chronic organ damage
  • cognitive impairment
  • frequent hospitalizations
  • school and work difficulties
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do RBCs differ in SCD and what problems does this cause?

A

RBCs are bioconcave

  • problem because RBC cannot get through microvasculature=impair circulation
  • causes clotting and sludging
  • sickled hemoglobin polymerization-fibrin=hard edges
  • causes membrane damage
  • abnormal shape=marked for destruction
  • stasis of blood flow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What the clinical manifestations of SCD?

A
  • impaired circulation
  • destruction of RBCs
  • stasis of blood flow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is hemoglobin solubility affected by SCD?

A

In the oxygenated state it is the same, but in the deoxygenated state-the HbS is less soluble= see fibrin deposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the cause of sickled RBCs?

A

In the deoxygenated state, the solubility of HbS is lowered and the RBC becomes unstable and goes into the sickled state

  • for a while it will cycle between the two shapes but eventually becomes damaged and looses its flexibility and the cell becomes permanentally sickled
  • this is when you start to see obstruction of blood flow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is an irreversibly sickled cell? What happens when cells become irreversibly sickled?

A
  • continual replications of shape causes loss of membrane flexability and fibrin deposits and eventually the cell becomes permanently sickled
  • this leads to slow blood flow through microcirculation and causes the sickled cells to adhere to endothelial cells= tissue damage=release of tissue factor=release of platlets= clotting cascade=further complicates circuation problems
  • this further increases blood flow obstruction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does SCD affect the RBC life span and how will this show up on labs?

A

The lifespan is much shorter (goes from a few months to 16-20 days)

  • low Hb on labs
  • body recognized not normal and markers for destruction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does SCD affect the spleen and what is the result of this?

A

Obstruction of blood to spleen causes functional asplenia

  • this increases susceptibility to infection
  • spleen is generally what cleans out RBCs marked for destruction so it can get very large = spleen not working as well=increased risk for infection
  • too busy destorying marked RBCs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why do people with SCD tend to have coagulation abnormalities and bleeding events

A
  • as sickle cells cause damage to microvasculature, tissue factor is being release and overconsumption of clotting factor
  • at risk for bleeding events
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What types of infection are those with SCD especially susceptible to?

A

-encapsulated organisms
(pneumococcal bacteria)
-group B strep
-Haemophilis influenzae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

When does SCD present and what does it present as?

A

Within first year of life= Typically 4-6 months after birth (that’s how long HbF takes to change to S)

  • labs=hemolytic anemia- continually drop
  • vaso-occlusion=pain and swelling in hands and feet
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How are children typically diagnosed with sickle cell disease?

A

genetic screening at birth

  • typically don’t have to present with problems
  • get on therapies early
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What symptoms will someone with SCD present with if not previously screened

A
  • pallor
  • fever
  • arthralgia
  • abdominal pain
  • weakness/fatigue (hemolytic anemia)
  • anorexia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are some clinical findings you would see in SCD?

A
  • enlargement of liver, spleen and hear from sequestered blood cells
  • hematuria (blood in urine)
  • low Hb
  • elevated reticulocytes-body trying to make up
  • elevated WBC/platlets from stress
  • will see sickled RBC in peripheral blood
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How is SCD generally treated?

A
  • no cure except bone marrow transplant-but most don’t do it
  • disease modifying therapies
  • preventive medical interventions
  • supportive care-role of pharmacist- pain meds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the goals of SCD therapy?

A

-important to start early and to see specialists
-reduce hospitalizations and complications
-increase life span
(average=42-48)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are important immunizations for those with SCD?

A

Pneumococci (prevnar-PCV13 between age 6-18 and pnuemovax-PPSV23 at age 2 and every 5 years)
-Influenza-pulmonary problems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What pneumococci vaccine is recommended for functional asplenia?

A

Pneumovax

  • PPPSV23
  • every 5 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

When is pnumovax (PPSV23) given and why?

A

At age 2 and every 5 years because it induces a poor antibody response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

When is penicillin prophylaxis given to those with SCD and what is the dosing regimen?

A
  • PCN 125mg BID until age 3
  • PCN 250mg BID though age 5
  • No benefits at age 6 and above unless history of invasive pneumococcal infection or surgical splenectomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What disease modifying agents are available for SCD and what do they do?

A
  • fetal hemoglobin inducers

- increase HbF which correlates with decreased sickling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is the goal HbF levels in disease modifying therapy?

A

levels of greater than 20% reduce risk of complications

-low HbF=more frequent pain and mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What agents can be used to induce fetal hemoglobin?

A

hydroxyurea=most common

decitabine-for hydroxyurea non-responders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

How does hydroxyurea stimulate HbF production?

A

Exact mechanism unknown

  • possible cytotoxic effect on bone marrow (also used for leukemia) stimulates stress erythropoiesis triggering HbF production?
  • nitric oxide released from metabolism may contribute to vasodilation= more room for sickle cells
  • increases RBC size and improves cellular deformability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are important points from the MSH trial and other trials of hydroxyurea use in SCD?

A
  • reduced painful episodes, ACS (acute chest syndrome) , need for blood transfusion and mortality
  • really showed importance because patient felt better and lived longer
  • if you start it early (after 9 months) can even prevent some end organ damage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What are the indications for hydroxyurea?

A
  • frequent pain episodes
  • severe anemia
  • history of ACS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What should patients diagnosed with SCD be started on no matter how many pain crisis they are having?

A

hydroxyurea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Is hydroxyurea safe to use in children?

A

Yes, does not appear to impact growth and development

  • may start at 9 months
  • may even preserve splenic function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Can hydroxyurea be used for stroke prevention?

A

Yes, has shown some effectiveness if patient doesn’t tolerate transfusion therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What side effects should you keep in mind about hyroxyurea?

A
  • bone marrow suppression (recover within 2 weeks of holding therapy)
  • abndmial pain
  • elevated LFTs-liver function tests
  • Alopecia (patchy hair loss and thinning)
  • reproductive-teratogenic- but has been done-talk to doctor
  • WATCH contamination
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What monitoring is required by hydroxyurea?

A
  • check CBC monthly (weekly for first month) and hold doses for bone marrow suppression seen as decrease in WBC, hemoglobin and platlets
  • renal and liver function tests-hold dose for greater than 50% decrease in SrCr or 100% increase in liver function tests
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What should you do if you notice low WBC (AN less than 500) and platelets in a patient on hydroxyurea?

A

-hold hydroxyurea for about 2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Why is chronic blood transfusion therapy given to SCD patients?

A
  • to prevent stroke

- reduced frequency of vaso-occulsive pain and ACS if they don’t tolerate hydroxyurea or it doesn’t work

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What is the goal of chronic transfusion therapy?

A

Maintain HbS levels of less than 30%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

How often are transfusions given in chronic transfusion therapy?

A

Every 3-4 weeks, adjusted to maintain less than 30% HbS cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

What are the risks of chronic transfusion therapy?

A

Alloimmunization-antibodies to RBCs that destory them

  • Iron overload=end organ damage
  • hyper-viscosity-blood thicker-risk for clots
  • viral transmission-more safe now
  • volume overload
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

What are patients on chronic transfusion therapy counseled to avoid extra iron?

A

there is a risk for iron overload-which can cause end organ damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

What is used to treat iron overload?

A
  • iron chelators
  • desferal- SC or IV infuson (falling out of favor)
  • deferasirox (Exjade)- oral- dissolved in OJ, apple juice, water-does have REMS control
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Why are SCD patients at higher infection risk?

A

-functional asplenia and impaired antibody production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

How can infections be prevention in SCD?

A

vacinations and PCN prophylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

When does a person with SCD need to be evaluated to determine if they have an infection?

A

If they have a fever of greater than 101

  • can get really sick, really fast
  • need IV antibiotics quickly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

What are the criteria for hospitalization of patients with SCD for infection if fever over 101

A
  • fever over 104
  • infant less than 1
  • WBC over 30,000
  • history of bactremia/sepsis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

What infections are SCD patients at higher risk for?

A

encapsulated organisms such as streptococcus pneumonia, haemophilus influezae, neisseria meningitidis, salmonela

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

What are good antibotic options for infections in SCD?

A

ones that cover encapsulated organisms such as ceftriaxone, ceotaxime or clindamycin if PCN allergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

What are acute complications of SCD?

A

infection, neurologic, acute chest syndrome, splenic sequestration, pain crisis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

What is the cause of neurologic SCD complications?

A

cerebrovascular occlusion

-can cause overt stroke, headache, paralysis, aphasia, visual disturbances, facial droop and seizure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Who is at highest risk for neurologic SCD complications?

A
  • increased risk with increasing age
  • highest risk when very young
  • high risk of recurrence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Treatment for cerebrovasucalr occusion as a result of SCD?

A
  • hospitalization
  • transfusions to maintain HbS below 30%
  • children-start chronic tranfusions
  • need to check with CT scans and MRIs every 2 hours in hospital
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

What is the causes of acute chest syndrome (ACS) in SCD?

A

vaso-occlusive crisis in pulmonary vasculature

  • tissue damage
  • can cause secondary infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

What does ACS present as?

A

=pumonary infiltrate
cough, shortness of breath dyspnea, tachypena=increased respitory rate (35-50) chest pain, fever, wheezing, new onset hypoxia (low O2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Why start antibiotic therapy when a patient presents with ACS?

A

Risk for infection secondary to the pulmonary occlusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

What are risk factors for ACS in SCD?

A

young age (typically less than 5) , higher Hb, higher leukocytes, history of asthma, smoke exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

What should be done to treat ACS in SCD?

A
  • pain management (without analgesic induced hypoventilation)
  • use broad spectrum antibiotics early (macrolide or quinolone) for secondary infection
  • oxygen in hypoxic or acute stress
  • transfusion if severe with worsening hypoxia and increased work of breathing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

What happens during splenic sequestration in SCD?

A

sudden massive enlargement of spleen

  • sickled RBCs sequestered in parenchyma (a lot of RBC’s to destroy)
  • Hb falls quickly
  • decrease in circulating blood= hypotension and hypovolemia shock
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

What can repeated splenic infarction causes?

A

autospenectomy- spleen there but doesn’t function-called functionally asplenic
-generally really young patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Who is at most risk for splenic sequestration?

A

Infants and children

  • declines in adolescence
  • spleen don’t really function anymore so the blood doesn’t go there
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Treatment of splenic sequestration?

A
  • RBC transfusion to correct hypovolemia and high HbS
  • broad spectrum antibiotics to prevent infection from precipitating sequestration
  • splenectomy in life threatening or repetitive episodes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

What is the cause of pain crisis in SCD?

A

-vaso-occulusion leading to bone and muscle infarctions at single or multiple sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

What is the most common reason for hospitalization from SCD?

A

pain crisis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

What are risk factors for pain crisis?

A

fever, infection, dehydration, hypoxia, acidosis

-stressful times in life can trigger

67
Q

How do you treat mild pain crisis from SCD?

A

mild-outpatient-oral analgesics (NSAIDS, acetaminophen), fluids, rest- if persistent add opioid combo (Norco, Percocet)

68
Q

How do you treat moderate to severe pain crisis from SCD?

A

hospitalization, transfusions, fluids if dehydrated

69
Q

How do you treat moderate pain crisis from SCD?

A

combo therapy with opioid (Norco, Percocet)

70
Q

How do you treat severe pain crisis from SCD?

A

aggressively with opioids (morphine, hydromorphone, fentanyl, methadone-helps with neuropathic pain)

71
Q

Why do patients with SCD need high dose opioids long term?

A

tolerance develops

  • in severe pain
  • NOT opoid navie
  • can try a different
  • talk to the patient about what works with them
72
Q

What is PCA or patient controlled analgesia?

A

for severe pain for pain crisis

73
Q

Advantage of PCA in pain crisis

A

better monitoring of patient’s drug use

less risk of over/under dosing

74
Q

Disadvantage of PCA in pain crisis

A

cost

continuous narcotic

75
Q

Controllable elements in PCA

A
  • drug chosen
  • basal rate
  • PCA interval
  • PCA bolus dose
76
Q

What are the complications from pain crisis?

A
  • may develop neuropathic pain- doesn’t respond to traditional opiods (methadone will work)
  • may miss school for days (watch for kids wanting this)
  • develop drug familiarity and can be mistaken for drug seekers
77
Q

Chronic pulmonary and cardiac complications of SCD?

A
  • pulmonary hypertension
  • cardiac enlargment
  • LVEF (left ventricular ejection fraction) decreased
78
Q

Chronic skeletal complications of SCD?

A

osteonecrosis and osetomyelitis

79
Q

Chronic ocular and GI complications of SCD?

A
  • retinal hemorrhage

- cholelithiasis

80
Q

Chronic renal complications of SCD?

A
  • sickle cell nephropathy

- chronic renal failure in 30%

81
Q

Chronic growth and psychiatric complications of SCD?

A
  • depression and anxiety

- delayed growth and development

82
Q

What patients may be appropriate for a allogenic stem cell transplant?

A
  • younger than 16
  • severe form of SCD with a lot of complications
  • available sibling dono
83
Q

What is the only cure for SCD? Why don’t more patients do it?

A
  • allogeneic stem cell transplant
  • significant toxicities- high dose chemo, 40% mortality
  • giving a new immune system, have graft vs host problems
84
Q

What is a mab in the works for SCD? How does it work?

A

Crizanlizumab

  • binds P selection and blocks gp ligand 1
  • decrease number of pain crisis
85
Q

What is hemophilia?

A

group of related bleeding disorders that are inherited

vWD, hemophilia A/B

86
Q

Is von Willebrand disease, Hemophilia A or B more common?

A

von willebrand disease

87
Q

Where is hemophilia most found?

A

evenly distributed geographically and racial groups

88
Q

Who does vWD affect?

A

1% of population

males = females

89
Q

Who does hemophilia A affect?

A

1/5000 male births

90
Q

factor VIII deficiency

A

hemophilia A

91
Q

factor IX deficiency

A

hemophilia B

92
Q

Who does hemophilia B affect?

A

1/30,000 male births

93
Q

Etiology of hemophilia

A

X linked inherited disorder

Females obligate carriers

Spontaneous mutation in 33% of males

94
Q

Symptomatic female carriers of hemophilia

A

mild disease

95
Q

Role of vWF

A

platelet adhesion (site of vascular injury)

96
Q

What happens in defects in vWF?

A

decreased platelet adhesion

bleeding of mucous membranes/soft tissues

97
Q

role of factor VIII carrier protein

A

increases half life: minutes to hours

98
Q

Type I vWD

A

reduction in normally functioning vWF

99
Q

Type 2 vWD

A

dysfunctional vWF

100
Q

Type 3 vWD

A

complete absence of vWF

101
Q

Severe hemophilia

A

<1% factor activity or <0.01 IU/mL

spontaneous bleeding more common

102
Q

Moderate hemophilia

A

> 1 and <5% factor activity

103
Q

Mild hemophilia

A

> 5% to <40% factor activity

104
Q

At what age do you start to see initial presentation of hemophilia?

A

3 months to 2 years

  • later onset with mild/moderate
105
Q

Initial presentation of hemophilia

A

suspicious bleeding events (bleeding with circumcision)

106
Q

Common bleeding sites in initial presentation of hemophilia

A
  • CNS
  • hemarthrosis
  • skeletal muscle
  • GI tract
  • GEN tract
  • post traumatic bleeding
107
Q

Hemarthrosis in infants in hemophilia

A

irritability

decreased use of limb

108
Q

hemarthrosis in children in hemophilia

A

prodromal stiffness
warm sensation
acute pain and swelling

109
Q

CNS bleeding site in hemophilia

A
  • intracranial hemorrhage
  • HA, vomiting, lethargy
  • seizure in perinatal period
110
Q

Skeletal muscle bleeding site in hemophilia

A
  • quadriceps, forearm

- severe = loss of limb

111
Q

GI tract bleeding site in hemophilia

A
  • lesions anywhere along GI tract

- hematoma of bowel wall (pseudo appendicitis)

112
Q

Post traumatic bleeding in hemophilia

A

delayed bleeding common

may persist for weeks

113
Q

GEN tract bleeding in hemophilia

A

hematuria: benign

114
Q

Prognosis of hemophilia if no treatment

A

severe disease premature death

115
Q

Prognosis of hemophilia if standard factor replacement therapy

A

life expectancy approaches general population

116
Q

Long term complications of hemophilia

A
  • joint abnormalities
  • transmission of inaction
  • development of inhibitors
117
Q

Join destruction in hemarthrosis

A
  • tissue deposition of iron
  • dense fibrosis/contractures
  • limitation of motion
118
Q

risk factors of hemarthrosis

A
  • older age
  • non-Caucasian
  • increased BMI
119
Q

number and severity of bleeding with hemarthrosis

A
  • correlate with function and QOL

- chronic pain and disability

120
Q

Additional therapy for hemarthrosis

A
  • GC burst (reduce synovial inflammation)
  • joint aspiration (factor replacement)
  • rest and splinting of joint (followed by ROM)
121
Q

Infection and hemophilia

A
  • reduced with donor screening and virucidal techniques
122
Q

Older factor VIII/IX products are at high risk for

A

hep B and C
HIV
hepatocellular carcinoma

123
Q

Current infectious risks of factor VIII/IX

A

parvovirus B19

CJD

124
Q

Goal of therapy for bleeding episodes in hemophilia

A
  • replace deficient endogenous protein
125
Q

Management strategies for bleeding episodes in hemophilia

A

PRN treatment

prophylaxis

126
Q

Desmopressin can be used for what hemophilia type?

A

vWD

- bleeding episodes and prevention

127
Q

T/f you can give desmopressin more than every 24 hours

A

false
- tachyphylaxis occurs if more than 24 hours
depletion of vWF from endothelial stores

128
Q

ADE of desmopressin

A
  • dose and age related
  • facial flushing
  • HA
  • HTN
  • retention of free water
129
Q

Factor VIII concentrates can be used for what diseases?

A

hemophilia A

vWD

130
Q

Factor IX concentrates can be used for what diseases?

A

hemophilia B

131
Q

How do factor concentrates work?

A

provide deficient protein allowing for hemostasis

132
Q

Where do factor concentrates come from?

A

plasma source

recombinant product

133
Q

What do you consider with dosing factor concentrates?

A
  • site and severity of bleed
  • type of hemophilia
  • presence of inhibitor
134
Q

What do you consider with target concentration with factor concentrates?

A

depends on bleed

- less severe lower concentrations for shorter periods than severe bleeding events

135
Q

How else can you give factor concentrates?

A

bolus therapy

VIII: 8-24 hours
IX: 12-24 hours

136
Q

Factor concentrate monitoring

A
  • after admin of factor
  • immediately before surgery
  • daily to achieve target concentrations
137
Q

goal of prophylactic therapy in hemophilia

A
  • maintain factor levels >1%

factor 25-40 units/kg 3 times per week

138
Q

Primary prophylactic therapy in hemophilia

A
  • regular replacement starting at 2 years

- done before bleeding event

139
Q

Secondary prophylactic therapy in hemophilia

A
  • started >1 bleed into target joint

- prevent further joint/organ damage

140
Q

Intermittent prophylactic therapy in hemophilia

A
  • moderate/mild deficiency

- based on activity and factor level

141
Q

Concerns with prophylactic therapy in hemophilia

A
  • cost $$$$
  • central venous access
  • thrombosis risk
  • infection
  • commitment
  • unnecessary treatment
142
Q

Plasma products

A

factor purified from humans with monoclonal antibodies

143
Q

factor product selection

A
  • risk of viral transmission

- categorized based on purity

144
Q

Recombinant products

A

genetically engineered proteins produced in animal or human cell lines

  • made from modified VIII gene
145
Q

What cells can you get modified factor VIII?

A
  • baby hamster kidney (BHK)
  • chinese hamster ovary (CHO)
  • human embryonic kidney cells (HEK)
146
Q

First gen factor selection

A
  • contain bovine/human proteins in culture medium AND final product
147
Q

second gen factor selection

A

bovine or human proteins in culture medium, NOT in final product
- stabilized with sucrose

148
Q

third gen factor selection

A

NO bovine or human proteins

149
Q

What have factor VIII and vWF products?

A
  • Humate-P
  • Koate-DVI
  • Alphanate
  • Wilate
150
Q

What have factor IX plasma source?

A

PMonoNine

AlphaNine

151
Q

What have factor IX third gen recombinant?

A

BeneFIX
Ixinity
Rixubis

152
Q

What factor VIII products are long acting?

A

Adynovate
Eloctate
**10-22 half life

153
Q

What factor IX products are long acting?

A

Alprolix
Idelvion
***66-93 half life

154
Q

Inhibitors in hemophilia

A

development of antibodies to neutralize factor
30% severe hem A
3-5% severe hem B

155
Q

Clinical manifestations of inhibitors in hemophilia

A

increase in bleeding frequency

difficulty treating bleeding episodes

156
Q

How are inhibitors measured in hemophilia?

A

bethesda units

1BU = amount of inhibitor needed to inactivate 50% of FVIII in equal volume of pooled plasma

157
Q

Treatment of acute bleeding with inhibitors in hemophilia

A
  • high dose factor replacement (low inhibitor)
  • recomb VIIa
  • FEIBA
  • Obizur
  • immunotherapy
158
Q

Obizur is only for what hemophilia?

159
Q

Immune tolerance induction (ITI) in inhibitor hemophilia

A

60-80% effective

  • repetitive doses of VIII
  • maintained by continued exposure to factor VIII
160
Q

Alternative agent for hemophilia

A

emicizumab

161
Q

Prophylaxis with emicizumab

A
  • with or w/o inhibitors
  • helpful in ITI ineffective
    NOT FOR ACUTE BLEEDS
162
Q

HAVEN 1 trial

A

emicizumab: prophylaxis with inhibitors

163
Q

HAVEN 3 trial

A

emicizumab: prophylaxis without inhibitors

164
Q

BBW for emicizumab

A

thrombotic events and thrombotic microangiopathy

**patients with inhibitors receiving bypassing agent